Search
for

    Sort by

    Research 391–420 of 1000+

    1. Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways Archives of dermatological research · 2024
    2. The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes 2024
    3. Aim to alleviate alopecia areata with newly available agents Drugs & Therapy Perspectives · 2024
    4. Novel investigational drugs for alopecia areata and future perspectives Expert opinion on investigational drugs · 2024
    5. Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor JEADV clinical practice · 2024
    6. Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies Current issues in molecular biology · 2024
    7. Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib 2024
    8. Could baricitinib treat frontal fibrosing alopecia and facial papules? Journal of Clinical Images and Medical Case Reports · 2024
    9. Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata Dermatologic therapy · 2024
    10. Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata JEADV Clinical Practice · 2023
    11. Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata Aktualʹnì problemi sučasnoï medicini · 2023
    12. Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran Journal of Cosmetic Dermatology · 2023
    13. 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege 2023
    14. Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review Acta dermato-venereologica · 2023
    15. Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data Dermatology and Therapy · 2023
    16. A superb way to split hairs British Journal of Dermatology · 2023
    17. 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib Journal of the American Academy of Dermatology · 2023
    18. 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2 Journal of The American Academy of Dermatology · 2023
    19. Topical metformin as a novel therapy for alopecia areata due to its immunologic effects Medical Hypotheses · 2023
    20. Survey of pediatric dermatologist views on treatment for alopecia areata JAAD international · 2023
    21. Treatment modalities for lymphocytic and neutrophilic scarring alopecia Journal of The American Academy of Dermatology · 2023
    22. Androgenetic alopecia: An update JAAD International · 2023
    23. Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about? Dermatology and therapy · 2023
    24. An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article ˜The œEgyptian Journal of Hospital Medicine · 2023
    25. P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2 British Journal of Dermatology · 2023
    26. Systemic immunotherapies Elsevier eBooks · 2023
    27. ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata. 2023
    28. A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata International Journal of Trichology · 2023
    29. Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata International Journal of Trichology · 2023
    30. Review of efficacy of baricitinib in the treatment of alopecia areata International Journal of Research in Dermatology · 2023